Patents
Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
01/2009
01/15/2009WO2008097546A3 Compounds that inhibit cholinesterase
01/15/2009US20090018116 Therapeutic Compounds
01/15/2009US20090017003 Thiosulfonate anti-inflammatory agents
01/14/2009EP1789395B1 Method for chiral inversion of (s)-(+)- and (r)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and optically enriched mixtures thereof
01/14/2009CN101343249A Preparation of 3-(3-chlorine propyl)-7, 8-di methoxy-1, 3-dihydrogen-2H-3-benzo aza -ketone
01/14/2009CN100450619C Method for producing epsilon-carpolactam and method for reactivating catalyst for producing epsilon-carpolactam
01/13/2009US7476675 Quinolinone derivatives and uses thereof
01/08/2009WO2008065681A3 Process for preparation of ivabradine hydrochloride
01/08/2009US20090012057 Cardiovascular Compounds Comprising Nitric Oxide Enhancing Groups, Compositions and Methods of Use
01/07/2009EP2010499A1 Pharmaceutical compositions of oxcarbazepine with a median particle size of 15 to 30 microns
01/07/2009EP2010498A1 Synthesis of acylaminoalkenylene amides useful as substance p antagonists
01/07/2009EP2010289A2 Benzoazepin-oxy-acetic acid derivatives as ppar-delta agonists used for the increase of hdl-c, lower ldl-c and lower cholesterol
01/07/2009EP1680405B1 Bengamide derivatives and use thereof for the treatment of cancer
01/06/2009US7473779 e.g. 2-amino-N-(4-{[amino(2-thienyl)methylidene]amino}phenethyl)-5-methoxybenzamide; nitric oxide NO-synthase enzymes inhibitor; selective or non selective traps for reactive oxygen species; antiproliferative, antiinflammatory agent
01/06/2009US7473697 2-Oxo-piperidinyl- and 2-oxo-azepanyl alkanoic acid derivatives for the treatment of epilepsy and other neurological disorders
01/06/2009US7473688 Indolobenzazepine HCV NS5B inhibitors
01/06/2009CA2414095C Novel compounds
12/2008
12/31/2008WO2009001968A1 Benzazepine derivatives useful as vasopressin antagonists
12/31/2008WO2009001817A1 COMPOUND HAVING 11β-HSD1 INHIBITORY ACTIVITY
12/31/2008WO2006078753B1 N-substituted heterocyclic sulfonamides
12/31/2008WO2006078753A4 N-substituted heterocyclic sulfonamides
12/31/2008EP2007731A2 Process for the preparation of caprolactam cgrp antagonist intermediate
12/31/2008CA2690335A1 Benzazepine derivatives useful as vasopressin antagonists
12/25/2008US20080318930 Sulfonyl Compound as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase-1
12/25/2008US20080318928 Bengamides with a substituted caprolactam cycle, method for the preparation thereof, compositions containing them and use thereof
12/24/2008EP2006283A2 Process for production of amides or lactams
12/24/2008EP2004610A1 Preparation of eslicarbazepine and related compounds by asymmetric hydrogenation
12/24/2008EP2004599A2 Process for the preparation of an n-alkyl lactam with improved colour quality
12/24/2008EP1461306B1 Quaternary ammonium compounds and their use as antimuscarinic agents
12/24/2008CN101328146A Preparation of 5-cyano imino stilbene
12/23/2008US7468365 Lactam compound
12/18/2008WO2008154347A1 Spirobenzoazepines as vasopressin antagonists
12/18/2008US20080312432 Stabilizers for Use in Nvp Synthesis
12/18/2008US20080312212 Organic Compounds
12/17/2008EP2001852A2 Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto
12/16/2008US7465726 Substituted pyrrolo[2.3-B]pyridines
12/16/2008US7465723 Use of carboxamides for the treatment of tinnitus
12/11/2008WO2008150954A1 Treatment of age-related macular degeneration
12/11/2008WO2008150842A1 Ionic liquids as electrolytes
12/11/2008US20080306065 Metalloproteinase Inhibitors
12/11/2008US20080306044 Spirobenzoazepanes as vasopressin antagonists
12/11/2008US20080306036 Triphenylethylene Compounds Useful as Selective Estrogen Modulators
12/11/2008CA2688439A1 Treatment of age-related macular degeneration
12/10/2008EP2000142A1 Method for treating severe heart failure and medicament therefor
12/10/2008CN100441188C Benzazepine derivatives as MAO-B inhibitors
12/09/2008US7462628 Preventives/remedies for urinary disturbance
12/04/2008WO2008146308A2 Process for the preparation of ivabradine hydrochloride and polymorph thereof
12/03/2008EP1997495A1 2-phenoxy- and 2-phenylsulfanyl-benzenesulfonamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
12/03/2008EP1996202A1 Chemical compounds
12/03/2008EP1430031B1 Kinetic resolution of a intermediate useful in the production of benazepril and analogues thereof
12/03/2008CN101314590A Chemical synthesis method for oxcarbazepine
12/02/2008US7459553 Process for the preparation of carboxamide compounds
12/02/2008US7459473 1-(phenylmethyl)sulfonyl-2-hydroxymethyl pyrrolidine for example; use treating neurological disorders including physically damaged nerves and neurodegenerative diseases; treating alopecia and promoting hair growth
12/02/2008CA2407812C Method for producing cyclic lactams
11/2008
11/27/2008WO2005025498A3 Substituted acetanilides and benzamides for the treatment of asthma and pulmonary inflammation
11/27/2008US20080293934 Method for Chiral Inversion of (S)-(+)-and (R)-(-)-10,11-Dihydro-10-Hydroxy-5H-Dibenz/B,F/Azepine-5-Carboxamide and Optically Enriched Mixtures Thereof
11/27/2008US20080293695 Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistance
11/27/2008US20080293692 Amidating a succinamic acid with a 3-aminolactam to prepare compounds, such as N1-[1,3-dihydro-1-(3-phenoxybenzyl)-2-oxo-5-(phenyl)-2H-1,4-benzodiazepin-3-yl]-2-(2-methylpropyl)-3-(allyl)-butanediamide
11/27/2008US20080293678 Organic Nitric Oxide Donor Salts of Angiotensin Converting Enzyme Inhibitors, Compositions and Methods of Use
11/26/2008CN101312947A Polyamide depolymerization method and polyamide monomer preparation method
11/26/2008CN100436454C Novel harringtonlne derivative, method for making same and its pharmaceutical composition and use thereof
11/26/2008CN100436423C Chemically synthetic method for N-chloroformyl imino dibenzyl
11/26/2008CN100436422C Chemically synthetic method for N-chloroformyl imino dibenzyl
11/25/2008US7456567 organic electroluminescent device having a pair of electrodes, and at least one organic layer interposed between the pair of electrodes, with the organic layer containing at least one compound represented by formula (1):** Image-1
11/25/2008US7456278 Lactams substituted by cyclic succinates as inhibitors of Aβ protein production
11/25/2008US7456172 Succinoylamino benzodiazepines as inhibitors of Aβ protein production
11/25/2008US7456167 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
11/25/2008US7456165 Activity against hepatitis C virus; for example, 13-cyclohexyl-6-(1H-tetrazol-5-yl)-7H-indolo[2,1-a][2]benzazepine-10-carboxylic acid, methyl ester
11/25/2008CA2224369C Aromatic acid diamides with antigastrin activity, a method for their preparation and their pharmaceutical use
11/20/2008WO2008141082A1 Aryloxy-and heteroaryloxy-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
11/20/2008WO2008141081A1 Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
11/20/2008US20080287419 Apoptosis promoters
11/20/2008CA2685861A1 Aryloxy-and heteroaryloxy-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
11/20/2008CA2685860A1 Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
11/19/2008CN101309906A 8-substituted benzoazepines as toll-like receptor modulators
11/19/2008CN101307021A Chemical synthesis process for iminostilbene
11/18/2008US7452905 Phenylalanine derivatives
11/18/2008US7452876 8-Cyclohexyl-1,1a,2,12b-tetrahydro-1a-(4-morpholinylcarbonyl)-cycloprop[d]indolo[2,1-a][2]benzazepine-5-carboxylic acid, methyl ester; RNA polymerase, HCV metalloprotease, HCV serine protease, HCV polymerase, HCV helicase inhibitor; liver disease, including cirrhosis and hepatocellular carcinoma
11/18/2008US7452875 Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
11/13/2008WO2008135524A2 Substituted anthranilamides and analogues, manufacturing and use thereof as medicaments
11/13/2008WO2008066620A3 Dibenzothiazepine derivatives
11/12/2008CN101302198A Chemical synthetic method of azepine derivate
11/12/2008CN100432057C Crystalline form gamma-d of the chlorohydrate of ivabradine, process for its preparation and pharmaceutical compositions containing it
11/06/2008US20080275026 Benzamide derivatives as oxytocin agonists and vasopressin antagonists
11/06/2008US20080275025 Substituted Lactams and Their Use as Anti-Cancer Agents
11/06/2008US20080275024 Amyloid precursor protein/gamma-secretase inhibitors; amides of aminobenzodiazepines: 2-(3,5-difluorophenyl)-N {[N-(1-methyl-2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))carbamoyl]cyclohexyl}acetamide
11/05/2008EP1608374B1 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
11/04/2008US7446115 To treat pain, drug addiction, or tinnitus; selectively inhibit sodium or calcium ion channels and agonize or antagonize mu -opioid receptors; N-Benzyl-N-(2-dimethylamino-ethyl)-2-(S)-[3-(4-fluorophenyl)-ureido]-3-methyl-butyramide
11/04/2008US7446103 N-[4-(3-Piperidin-1-ylpropoxy)-benzoyl]-5-fluoroisoindoline; Alzheimer's disease; cognition enhancers; amidation
10/2008
10/30/2008WO2007121432A3 Benzoazepin-oxy-acetic acid derivatives as ppar-delta agonists used for the increase of hdl-c, lower ldl-c and lower cholesterol
10/30/2008US20080269480 Process for the Preparation of 10,11-Dihydro-10-Oxo-5H-Dibenz[B,F] Azepine-5-Carboxamide
10/30/2008US20080269197 antipsychotic agents; phenylsulfonyl compounds; 7-Methoxy-8-(3-phenoxy-benzenesulfonyl)-2,3,4,5-tetrahydro-1H-3-benzazepine; schizophrenia
10/30/2008US20080269196 Serotonin receptor antagonist; therapy obesity, obsessive compulsive disorders; antidepressants; anxiolytic agents
10/29/2008EP1985615A1 Method for producing benzazepinone
10/29/2008CN101296902A Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses
10/29/2008CN101294173A Method for the manufacture of bengamide derivatives
10/28/2008US7442447 Binaphthol based chromophores for the fabrication of blue organic light emitting diodes
10/23/2008WO2008125006A1 Preparation processes for ivabradine hydrochloride and its stable crystalline form
10/23/2008US20080262224 Method of Preparation of Benzofuran-2-Carboxylic Acid -Amide
10/23/2008US20080262223 Isolation of Galanthamine From Biological Material
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 88